Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/16/25 20:07 | 5/16/25 | PGEN | Health | Drug | Pharmaceutical Preparations | Shah Rutul R | MD | O | COO | 1 | M.d | 0 | 0.00 | 0 | 174 | 76 | 404 | D | ||||||||||||||
5/16/25 20:06 | 5/16/25 | PGEN | Health | Drug | Pharmaceutical Preparations | Tennant Phil | MD | O | Chief Co | 1 | M.d | 0 | 0.00 | 0 | 66 | 59 | D | |||||||||||||||
5/16/25 19:56 | 5/16/25 | PGEN | Health | Drug | Pharmaceutical Preparations | Lehr Donald P. | MD | O | GC | 1 | M.d | 0 | 0.00 | 0 | 165 | 32 | 682 | D | ||||||||||||||
5/16/25 19:54 | 5/16/25 | PGEN | Health | Drug | Pharmaceutical Preparations | Thomasian Harry Jr. | MD | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 154 | 51 | 457 | D | ||||||||||||||
5/16/25 19:52 | 5/16/25 | PGEN | Health | Drug | Pharmaceutical Preparations | Sabzevari Helen | MD | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 1,079 | 48 | 3,317 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |